tirzepatide compound vs semaglutide compound Tirzepatide: Which Is Right? FDA says 'no clinical need'

A Fella provider may prescribe a compounded medication if they determine its an appropriate part of your treatment plan

Amgens novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708), with data suggesting longer lasting and durable reductions in body weight compared with the popular glucagon-like peptide (GLP)-1 agonists currently on the marketNovo Nordisks Wegovy (semaglutide) and Eli Lillys Zepbound (tirzepatide)

Persistent heavy foam is a warning sign

The pharmacokinetic enhancement attenuated the peak of drug exposure combining with less dependence on GLP-1mediated pharmacology, and avoided the gastrointestinal adverse reactions of selective GLP-1 receptor agonist

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist available by prescription only